Background: Iron deficiency anemia affects 90% of children in Burkina Faso. These studies on the
effectiveness of injectable iron are rare in low-income countries with high infant and child mortality related to anemia.
Methods: This has been an observational study to assess the effectiveness of injectable iron in children under five years
old admitted to the pediatric ward of the Yalgado Ouédraogo University Teaching Hospital (YO-UTH), in 2019, in
Ouagadougou, Burkina Faso.
Findings: Thirty-five (35) children with severe iron deficiency anemia (average age 2.5 years), 60 %( n=21) of whom had
decompensated anemia and required transfusion, were treated with injectable iron polymaltose hydroxide and followed
up for one month. On average, 226.9± 45.5mg of iron were injected over an average treatment duration of three days.
The mean hemoglobin count increased from 4.7± 0.95g/dl at baseline to 9.7±1g/dl (an increase of 4.9g/dl) one month
later (p

Anemia iron deficiency child iron injectable